Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Differences in Physician Compensation Between Men and Women at United States Public Academic Radiation Oncology Departments.

Guss ZD, Chen Q, Hu C, Guss LG, DeWeese TL, Terezakis SA.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):314-319. doi: 10.1016/j.ijrobp.2018.09.042. Epub 2018 Oct 10.


Intensity-modulated involved-site radiation therapy for non-Hodgkin lymphoma of the head and neck.

Guss ZD, Madkhali A, Chen Q, Zhang Y, Dah S, Moore J, Terezakis SA.

Leuk Lymphoma. 2017 Nov;58(11):2755-2757. doi: 10.1080/10428194.2017.1312388. Epub 2017 May 9. No abstract available.


Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation.

Guss ZD, Moningi S, Jallo GI, Cohen KJ, Wharam MD, Terezakis SA.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1307-11. doi: 10.1016/j.ijrobp.2012.11.022. Epub 2013 Feb 20.


Radiosurgery of glomus jugulare tumors: a meta-analysis.

Guss ZD, Batra S, Limb CJ, Li G, Sughrue ME, Redmond K, Rigamonti D, Parsa AT, Chang S, Kleinberg L, Lim M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e497-502. doi: 10.1016/j.ijrobp.2011.05.006. Epub 2011 Jun 22. Review.


Radiosurgery for glomus jugulare: history and recent progress.

Guss ZD, Batra S, Li G, Chang SD, Parsa AT, Rigamonti D, Kleinberg L, Lim M.

Neurosurg Focus. 2009 Dec;27(6):E5. doi: 10.3171/2009.9.FOCUS09195. Review.


Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R.

J Neuroimaging. 2011 Apr;21(2):e50-6. doi: 10.1111/j.1552-6569.2009.00449.x.


Normal findings on brain fluid-attenuated inversion recovery MR images at 3T.

Neema M, Guss ZD, Stankiewicz JM, Arora A, Healy BC, Bakshi R.

AJNR Am J Neuroradiol. 2009 May;30(5):911-6. doi: 10.3174/ajnr.A1514. Epub 2009 Apr 15.


3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.

Neema M, Goldberg-Zimring D, Guss ZD, Healy BC, Guttmann CR, Houtchens MK, Weiner HL, Horsfield MA, Hackney DB, Alsop DC, Bakshi R.

Neuroimage. 2009 Jul 1;46(3):633-41. doi: 10.1016/j.neuroimage.2009.03.001. Epub 2009 Mar 10.


Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis.

Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz BI, Stazzone L, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R.

J Neuroimaging. 2009 Jan;19(1):3-8. doi: 10.1111/j.1552-6569.2008.00296.x.


Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL.

Arch Neurol. 2008 Nov;65(11):1449-53. doi: 10.1001/archneur.65.11.1449.


Neuroimaging of toxic and metabolic disorders.

Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, Bakshi R.

Semin Neurol. 2008 Sep;28(4):495-510. doi: 10.1055/s-0028-1083684. Epub 2008 Oct 8. Review.


MRI in multiple sclerosis: what's inside the toolbox?

Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R.

Neurotherapeutics. 2007 Oct;4(4):602-17. Review.


T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.

Neema M, Stankiewicz J, Arora A, Dandamudi VS, Batt CE, Guss ZD, Al-Sabbagh A, Bakshi R.

J Neuroimaging. 2007 Apr;17 Suppl 1:16S-21S. Review.


Supplemental Content

Support Center